New insights into basophil heterogeneity

Seminars in Immunopathology

Volumn 38, Issue 5, 2016, Pages 549-561

  Oetjen, Landon K ^a   Noti, Mario ^b   Kim, Brian S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 3; THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE;

ATOPIC DERMATITIS; B LYMPHOCYTE; BASOPHIL; CELL HETEROGENEITY; CELL MATURATION; CYTOKINE RESPONSE; EFFECTOR CELL; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE FUNCTION; LYMPHOID CELL; MACROPHAGE; MONOCYTE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; BONE MARROW CELL; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOLOGY; DISEASE PREDISPOSITION; EXTRACELLULAR SPACE; GENETICS; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; INTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY;

ANIMALS; BASOPHILS; BONE MARROW CELLS; CELL COMMUNICATION; CELL DIFFERENTIATION; CYTOKINES; DISEASE SUSCEPTIBILITY; EXTRACELLULAR SPACE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-3; INTRACELLULAR SPACE; SIGNAL TRANSDUCTION;

EID: 84968542307     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-016-0567-z     Document Type: Review

References (159)

1. P. Ehrlich (1878) Beiträge zur Theorie und Praxis der Histologischen Färbung, Leipzig University
2. Ishizaka T, De Bernardo R, Tomioka H, Lichtenstein LM, Ishizaka K (1972) Identification of basophil granulocytes as a site of allergic histamine release. J Immunol 108:1000–1008
3. Siracusa MC, Kim BS, Spergel JM, Artis D (2013) Basophils and allergic inflammation. J Allergy Clin Immunol 132:789–801. doi:10.1016/j.jaci.2013.07.046
4. Crivellato E, Nico B, Ribatti D (2011) The history of the controversial relationship between mast cells and basophils. Immunol Lett 141:10–17. doi:10.1016/j.imlet.2011.06.008
5. Schroeder JT (2009) Basophils beyond effector cells of allergic inflammation. Adv Immunol 101:123–161. doi:10.1016/S0065-2776(08)01004-3
6. Ogilvie BM, Hesketh PM, Rose ME (1978) Nippostrongylus brasiliensis: peripheral blood leucocyte response of rats, with special reference to basophils. Exp Parasitol 46:20–30
7. Ogilvie BM, Askenase PW, Rose ME (1980) Basophils and eosinophils in three strains of rats and in athymic (nude) rats following infection with the nematodes Nippostrongylus brasiliensis or Trichinella spiralis. Immunology 39:385–389
8. Roth RL, Levy DA (1980) Nippostrongylus brasiliensis: peripheral leukocyte responses and correlation of basophils with blood histamine concentration during infection in rats. Exp Parasitol 50:331–341. doi:10.1016/0014-4894(80)90036-3
9. Rothwell TL (1975) Studies of the responses of basophil and eosinophil leucocytes and mast cells to the nematode Trichostrongylus colubriformis. I. Observations during the expulsion of first and second infections by guinea-pigs. J Pathol 116:51–60. doi:10.1002/path.1711160109
10. Rothwell TLW, Dineen JK (1972) Cellular reactions in guinea-pigs following primary and challenge infection with Trichostrongylus colubriformis with special reference to the roles played by eosinophils and basophils in rejection of the parasite. Immunology 22:733–745
11. Dvorak AM, Nabel G, Pyne K, Cantor H, Dvorak HF, Galli SJ (1982) Ultrastructural identification of the mouse basophil. Blood 59:1279–1285
12. Schrader JW, Lewis SJ, Clark-Lewis I, Culvenor JG (1981) The persisting (P) cell: histamine content, regulation by a T cell-derived factor, origin from a bone marrow precursor, and relationship to mast cells. Proc Natl Acad Sci U S A 78:323–327
13. Voehringer D, Shinkai K, Locksley RM (2004) Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity 20:267–277. doi:10.1016/S1074-7613(04)00026-3
14. Min B, Prout M, Hu-Li J, Zhu J, Jankovic D, Morgan ES et al (2004) Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med 200:507–517. doi:10.1084/jem.20040590
15. Sawaguchi M, Tanaka S, Nakatani Y, Harada Y, Mukai K, Matsunaga Y et al (2012) Role of mast cells and basophils in IgE responses and in allergic airway hyperresponsiveness. J Immunol 188:1809–1818. doi:10.4049/jimmunol.1101746
16. Wada T, Ishiwata K, Koseki H, Ishikura T, Ugajin T, Ohnuma N et al (2010) Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest 120:2867–2875. doi:10.1172/JCI42680
17. Sullivan BM, Liang H-E, Bando JK, Wu D, Cheng LE, McKerrow JK et al (2011) Genetic analysis of basophil function in vivo. Nat Immunol 12:527–535. doi:10.1038/ni.2036
18. Karasuyama H, Yamanishi Y (2014) Basophils have emerged as a key player in immunity. Curr Opin Immunol 31:1–7. doi:10.1016/j.coi.2014.07.004
19. Siracusa MC, Saenz SA, Hill DA, Kim BS, Headley MB, Doering TA et al (2011) TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature 477:229–233. doi:10.1038/nature10329
20. Siracusa MC, Saenz SA, Tait Wojno ED, Kim BS, Osborne LC, Ziegler CG et al (2013) Thymic stromal lymphopoietin-mediated extramedullary hematopoiesis promotes allergic inflammation. Immunity 39:1158–1170. doi:10.1016/j.immuni.2013.09.016
21. Hammad H, Lambrecht BN (2015) Barrier epithelial cells and the control of type 2 immunity. Immunity 43:29–40. doi:10.1016/j.immuni.2015.07.007
22. Pulendran B, Artis D (2012) New paradigms in type 2 immunity. Science 337:431–435. doi:10.1126/science.1221064
23. Schwartz C, Eberle JU, Voehringer D (2016) Basophils in inflammation. Eur J Pharmacol 778:90–95. doi:10.1016/j.ejphar.2015.04.049
24. Voehringer D (2013) Protective and pathological roles of mast cells and basophils. Nat Rev Immunol 13:362–375. doi:10.1038/nri3427
25. Iwasaki H, Mizuno S, Arinobu Y, Ozawa H, Mori Y, Shigematsu H et al (2006) The order of expression of transcription factors directs hierarchical specification of hematopoietic lineages. Genes Dev 20:3010–3021. doi:10.1101/gad.1493506
26. Arinobu Y, Iwasaki H, Gurish MF, Mizuno S, Shigematsu H, Ozawa H et al (2005) Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc Natl Acad Sci U S A 102:18105–18110. doi:10.1073/pnas.0509148102
27. Sasaki H, Kurotaki D, Osato N, Sato H, Sasaki I, Koizumi S et al (2015) Transcription factor IRF8 plays a critical role in the development of murine basophils and mast cells. Blood 125:358–369. doi:10.1182/blood-2014-02-557983
28. Mukai K, BenBarak MJ, Tachibana M, Nishida K, Karasuyama H, Taniuchi I et al (2012) Critical role of P1-Runx1 in mouse basophil development. Blood 120:76–85. doi:10.1182/blood-2011-12-399113
29. Qi X, Hong J, Chaves L, Zhuang Y, Chen Y, Wang D et al (2013) Antagonistic regulation by the transcription factors C/EBPα and MITF specifies basophil and mast cell fates. Immunity 39:97–110. doi:10.1016/j.immuni.2013.06.012
30. Li Y, Qi X, Liu B, Huang H (2015) The STAT5–GATA2 pathway is critical in basophil and mast cell differentiation and maintenance. J Immunol 194:4328–4338. doi:10.4049/jimmunol.1500018
31. Nei Y, Obata-Ninomiya K, Tsutsui H, Ishiwata K, Miyasaka M, Matsumoto K et al (2013) GATA-1 regulates the generation and function of basophils. Proc Natl Acad Sci U S A 110:18620–18625. doi:10.1073/pnas.1311668110
32. Ohmori K, Luo Y, Jia Y, Nishida J, Wang Z, Bunting KD et al (2009) IL-3 induces basophil expansion in vivo by directing granulocyte-monocyte progenitors to differentiate into basophil lineage-restricted progenitors in the bone marrow and by increasing the number of basophil/mast cell progenitors in the spleen. J Immunol 182:2835–2841. doi:10.4049/jimmunol.0802870
33. Lantz CS, Boesiger J, Song CH, Mach N, Kobayashi T, Mulligan RC et al (1998) Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392:90–93. doi:10.1038/32190
34. Shen T, Kim S, Do J, Wang L, Lantz C, Urban JF et al (2008) T cell-derived IL-3 plays key role in parasite infection-induced basophil production but is dispensable for in vivo basophil survival. Int Immunol 20:1201–1209. doi:10.1093/intimm/dxn077
35. Voehringer D (2012) Basophil modulation by cytokine instruction. Eur J Immunol 42:2544–2550. doi:10.1002/eji.201142318
36. Schroeder JT, Chichester KL, Bieneman AP (2009) Human basophils secrete IL-3: evidence of autocrine priming for phenotypic and functional responses in allergic disease. J Immunol 182:2432–2438. doi:10.4049/jimmunol.0801782
37. Ohnmacht C, Voehringer D (2009) Basophil effector function and homeostasis during helminth infection. Blood 113:2816–2825. doi:10.1182/blood-2008-05-154773
38. Zheng X, Karsan A, Duronio V, Chu F, Walker DC, Bai TR et al (2002) Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways. Immunology 107:306–315. doi:10.1046/j.1365-2567.2002.01517.x
39. Didichenko SA, Spiegl N, Brunner T, Dahinden CA (2008) IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. Blood 112:3949–3958. doi:10.1182/blood-2008-04-149419
40. Gibbs BF, Haas H, Falcone FH, Albrecht C, Vollrath IB, Noll T et al (1996) Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol 26:2493–2498. doi:10.1002/eji.1830261033
41. MacGlashan D, White JM, Huang SK, Ono SJ, Schroeder JT, Lichtenstein LM (1994) Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol 152:3006–3016
42. Hida S, Yamasaki S, Sakamoto Y, Takamoto M, Obata K, Takai T et al (2009) Fc receptor γ-chain, a constitutive component of the IL-3 receptor, is required for IL-3-induced IL-4 production in basophils. Nat Immunol 10:214–222. doi:10.1038/ni.1686
43. Kamijo S, Nunomura S, Ra C, Kanaguchi Y, Suzuki Y, Ogawa H et al (2016) Innate basophil IL-4 responses against allergens, endotoxin, and cytokines require the Fc receptor γ-chain. J Allergy Clin Immunol 137:1613–1615.e2. doi:10.1016/j.jaci.2015.10.037
44. Bezbradica JS, Rosenstein RK, DeMarco RA, Brodsky I, Medzhitov R (2014) A role for the ITAM signaling module in specifying cytokine-receptor functions. Nat Immunol 15:333–342. doi:10.1038/ni.2845
45. Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, Kubo M et al (2012) Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 18:538–546. doi:10.1038/nm.2657
46. Hill DA, Artis D (2013) The influence of commensal bacteria-derived signals on basophil-associated allergic inflammation. Gut Microbes 4:76–83. doi:10.4161/gmic.22759
47. Cahenzli J, Köller Y, Wyss M, Geuking MB, McCoy KD (2013) Intestinal microbial diversity during early-life colonization shapes long-term IgE levels. Cell Host Microbe 14:559–570. doi:10.1016/j.chom.2013.10.004
48. Herbst T, Sichelstiel A, Schär C, Yadava K, Bürki K, Cahenzli J et al (2011) Dysregulation of allergic airway inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 184:198–205. doi:10.1164/rccm.201010-1574OC
49. Ohnmacht C, Park J-H, Cording S, Wing JB, Atarashi K, Obata Y et al (2015) The microbiota regulates type 2 immunity through RORγt + T cells. Science 349:989–993. doi:10.1126/science.aac4263
50. Chapuy L, Bsat M, Mehta H, Rubio M, Wakahara K, Van VQ et al (2014) Basophils increase in Crohn disease and ulcerative colitis and favor mesenteric lymph node memory TH17/TH1 response. J Allergy Clin Immunol 134:978–981. doi:10.1016/j.jaci.2014.05.025
51. Rodriguez Gomez M, Talke Y, Hofmann C, Ketelsen I, Hermann F, Reich B et al (2014) Basophils control T-cell responses and limit disease activity in experimental murine colitis. Mucosal Immunol 7:188–199. doi:10.1038/mi.2013.38
52. Lambrecht BN, Hammad H (2015) The immunology of asthma. Nat Immunol 16:45–56. doi:10.1038/ni.3049
53. Kimura I, Tanizaki Y, Saito K, Takahashi K, Ueda N, Sato S (1975) Appearance of basophils in the sputum of patients with bronchial asthma. Clin Allergy 5:95–98
54. Kepley CL, McFeeley PJ, Oliver JM, Lipscomb MF (2001) Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Respir Crit Care Med 164:1053–1058. doi:10.1164/ajrccm.164.6.2102025
55. Koshino T, Teshima S, Fukushima N, Takaishi T, Hirai K, Miyamoto Y et al (1993) Identification of basophils by immunohistochemistry in the airways of post-mortem cases of fatal asthma. Clin Exp Allergy 23:919–925
56. Duff AL, Pomeranz ES, Gelber LE, Price GW, Farris H, Hayden FG et al (1993) Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatrics 92:535–540
57. Agrawal R, Wisniewski J, Yu MD, Kennedy JL, Platts-Mills T, Heymann PW et al (2014) Infection with human rhinovirus 16 promotes enhanced IgE responsiveness in basophils of atopic asthmatics. Clin Exp Allergy 44:1266–1273. doi:10.1111/cea.12390
58. Kinet JP (1999) The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17:931–972. doi:10.1146/annurev.immunol.17.1.931
59. Kraft S, Kinet J-P (2007) New developments in FcϵRI regulation, function and inhibition. Nat Rev Immunol 7:365–378. doi:10.1038/nri2072
60. Bruhns P, Jönsson F (2015) Mouse and human FcR effector functions. Immunol Rev 268:25–51. doi:10.1111/imr.12350
61. Galli SJ, Tsai M (2012) IgE and mast cells in allergic disease. Nat Med 18:693–704. doi:10.1038/nm.2755
62. Tsai SH, Kinoshita M, Kusu T, Kayama H, Okumura R, Ikeda K et al (2015) The ectoenzyme E-NPP3 negatively regulates ATP-dependent chronic allergic responses by basophils and mast cells. Immunity 42:279–293. doi:10.1016/j.immuni.2015.01.015
63. Broide DH (2001) Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 108:S65–S71. doi:10.1067/mai.2001.116436
64. Cassard L, Jönsson F, Arnaud S, Daëron M (2012) Fcγ receptors inhibit mouse and human basophil activation. J Immunol 189:2995–3006. doi:10.4049/jimmunol.1200968
65. Malbec O, Daëron M (2007) The mast cell IgG receptors and their roles in tissue inflammation. Immunol Rev 217:206–221. doi:10.1111/j.1600-065X.2007.00510.x
66. Wu LC (2011) Immunoglobulin E receptor signaling and asthma. J Biol Chem 286:32891–32897. doi:10.1074/jbc.R110.205104
67. Schwartz C, Turqueti-Neves A, Hartmann S, Yu P, Nimmerjahn F, Voehringer D (2014) Basophil-mediated protection against gastrointestinal helminths requires IgE-induced cytokine secretion. Proc Natl Acad Sci U S A 111:E5169–E5177. doi:10.1073/pnas.1412663111
68. Milgrom H, Fick RB, Su JQ, Reimann JD, Bush RK, Watrous ML et al (1999) Treatment of allergic asthma with monoclonal anti-IgE antibody. N Engl J Med 341:1966–1973. doi:10.1056/NEJM199912233412603
69. Strunk RC, Bloomberg GR (2006) Omalizumab for asthma. N Engl J Med 354:2689–2695. doi:10.1056/NEJMct055184
70. Maurer M, Rosén K, Hsieh H-J, Saini S, Grattan C, Gimenéz-Arnau A et al (2013) Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med 368:924–935. doi:10.1056/NEJMoa1215372
71. Borkowski TA, Jouvin M-H, Lin S-Y, Kinet J-P (2001) Minimal requirements for IgE-mediated regulation of surface FcεRI. J Immunol 167:1290–1296. doi:10.4049/jimmunol.167.3.1290
72. Hill DA, Siracusa MC, Ruymann KR, Tait Wojno ED, Artis D, Spergel JM (2014) Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children. Allergy 69:674–677. doi:10.1111/all.12375
73. Lin H, Boesel KM, Griffith DT, Prussin C, Foster B, Romero FA et al (2004) Omalizumab rapidly decreases nasal allergic response and FcεRI on basophils. J Allergy Clin Immunol 113:297–302. doi:10.1016/j.jaci.2003.11.044
74. MacGlashan DW Jr, Bochner BS, Adelman DC, Jardieu PM, Togias A, McKenzie-White J et al (1997) Down-regulation of FcεRI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. J Immunol 158:1438–1445
75. Saini SS, MacGlashan DW, Sterbinsky SA, Togias A, Adelman DC, Lichtenstein LM et al (1999) Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. J Immunol 162:5624–5630
76. Zaidi AK, Saini SS, Macglashan DW (2010) Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab. J Allergy Clin Immunol 125:902–908. doi:10.1016/j.jaci.2009.12.996
77. MacGlashan DW (2007) Endocytosis, recycling, and degradation of unoccupied FcepsilonRI in human basophils. J Leukoc Biol 82:1003–1010. doi:10.1189/jlb.0207103
78. Eckman JA, Hamilton RG, Gober LM, Sterba PM, Saini SS (2008) Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol 128:1956–1963. doi:10.1038/jid.2008.55
79. Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK (2008) Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol 122:569–573. doi:10.1016/j.jaci.2008.07.006
80. Mukai K, Matsuoka K, Taya C, Suzuki H, Yokozeki H, Nishioka K et al (2005) Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity 23:191–202. doi:10.1016/j.immuni.2005.06.011
81. Egawa M, Mukai K, Yoshikawa S, Iki M, Mukaida N, Kawano Y et al (2013) Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 38:570–580. doi:10.1016/j.immuni.2012.11.014
82. Hashimoto T, Satoh T, Yokozeki H (2015) Protective role of STAT6 in basophil-dependent prurigo-like allergic skin inflammation. J Immunol 194:4631–4640. doi:10.4049/jimmunol.1401032
83. Bauer RN, Manohar M, Singh AM, Jay DC, Nadeau KC (2015) The future of biologics: applications for food allergy. J Allergy Clin Immunol 135:312–323. doi:10.1016/j.jaci.2014.12.1908
84. Garcia G, Magnan A, Chiron R, Contin-Bordes C, Berger P, Taillé C et al (2013) A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma. Chest 144:411–419. doi:10.1378/chest.12-1961
85. Allakhverdi Z, Comeau MR, Jessup HK, Yoon B-RP, Brewer A, Chartier S et al (2007) Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 204:253–258. doi:10.1084/jem.20062211
86. Kay AB, Clark P, Maurer M, Ying S (2015) Elevations in T-helper-2-initiating cytokines (interleukin-33, interleukin-25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (“idiopathic”) urticaria. Br J Dermatol 172:1294–1302. doi:10.1111/bjd.13621
87. Rocha R, Vitor AB, Trindade E, Lima R, Tavares M, Lopes J et al (2011) Omalizumab in the treatment of eosinophilic esophagitis and food allergy. Eur J Pediatr 170:1471–1474. doi:10.1007/s00431-011-1540-4
88. Noda S, Krueger JG, Guttman-Yassky E (2015) The translational revolution and use of biologics in patients with inflammatory skin diseases. J Allergy Clin Immunol 135:324–336. doi:10.1016/j.jaci.2014.11.015
89. Kim BS, Wang K, Siracusa MC, Saenz SA, Brestoff JR, Monticelli LA et al (2014) Basophils promote innate lymphoid cell responses in inflamed skin. J Immunol 193:3717–3725. doi:10.4049/jimmunol.1401307
90. Noti M, Wojno EDT, Kim BS, Siracusa MC, Giacomin PR, Nair MG et al (2013) Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 19:1005–1013. doi:10.1038/nm.3281
91. Giacomin PR, Siracusa MC, Walsh KP, Grencis RK, Kubo M, Comeau MR et al (2012) Thymic stromal lymphopoietin-dependent basophils promote Th2 cytokine responses following intestinal helminth infection. J Immunol 189:4371–4378. doi:10.4049/jimmunol.1200691
92. Noti M, Kim BS, Siracusa MC, Rak GD, Kubo M, Moghaddam AE et al (2014) Exposure to food allergens through inflamed skin promotes intestinal food allergy through the thymic stromal lymphopoietin–basophil axis. J Allergy Clin Immunol 133:1390–1399. doi:10.1016/j.jaci.2014.01.021
93. Liu Y-J (2006) Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203:269–273. doi:10.1084/jem.20051745
94. Gao P-S, Rafaels NM, Mu D, Hand T, Murray T, Boguniewicz M et al (2010) Genetic variants in thymic stromal lymphopoietin are associated with atopic dermatitis and eczema herpeticum. J Allergy Clin Immunol 125:1403–1407. doi:10.1016/j.jaci.2010.03.016
95. Kimura S, Pawankar R, Mori S, Nonaka M, Masuno S, Yagi T et al (2011) Increased expression and role of thymic stromal lymphopoietin in nasal polyposis. Allergy Asthma Immunol Res 3:186–193. doi:10.4168/aair.2011.3.3.186
96. Nagarkar DR, Poposki JA, Tan BK, Comeau MR, Peters AT, Hulse KE et al (2013) Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis. J Allergy Clin Immunol 132:593–600. doi:10.1016/j.jaci.2013.04.005
97. Ramasamy A, Curjuric I, Coin LJ, Kumar A, McArdle WL, Imboden M et al (2011) A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J Allergy Clin Immunol 128:996–1005. doi:10.1016/j.jaci.2011.08.030
98. Iijima H, Kaneko Y, Yamada H, Yatagai Y, Masuko H, Sakamoto T et al (2013) A distinct sensitization pattern associated with asthma and the thymic stromal lymphopoietin (TSLP) genotype. Allergol Int 62:123–130. doi:10.2332/allergolint.12-OA-0488
99. Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A et al (2010) Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 42:289–291. doi:10.1038/ng.547
100. Sherrill JD, Gao P-S, Stucke EM, Blanchard C, Collins MH, Putnam PE et al (2010) Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 126:160–165. doi:10.1016/j.jaci.2010.04.037
101. Li M, Hener P, Zhang Z, Kato S, Metzger D, Chambon P (2006) Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci U S A 103:11736–11741. doi:10.1073/pnas.0604575103
102. Allakhverdi Z, Comeau MR, Smith DE, Toy D, Endam LM, Desrosiers M et al (2009) CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol 123:472–478. doi:10.1016/j.jaci.2008.10.022
103. Smith SG, Gugilla A, Mukherjee M, Merim K, Irshad A, Tang W et al (2015) Thymic stromal lymphopoietin and IL-33 modulate migration of hematopoietic progenitor cells in patients with allergic asthma. J Allergy Clin Immunol 135:1594–1602. doi:10.1016/j.jaci.2014.12.1918
104. Hui CCK, Rusta-Sallehy S, Asher I, Heroux D, Denburg JA (2014) The effects of thymic stromal lymphopoietin and IL-3 on human eosinophil–basophil lineage commitment: Relevance to atopic sensitization. Immun Inflamm Dis 2:44–55. doi:10.1002/iid3.20
105. Calder PC (2001) Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36:1007–1024. doi:10.1007/s11745-001-0812-7
106. Lott JM, Sumpter TL, Turnquist HR (2015) New dog and new tricks: evolving roles for IL-33 in type 2 immunity. J Leukoc Biol 97:1037–1048. doi:10.1189/jlb.3RI1214-595R
107. Molofsky AB, Savage AK, Locksley RM (2015) Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity 42:1005–1019. doi:10.1016/j.immuni.2015.06.006
108. Muto T, Fukuoka A, Kabashima K, Ziegler SF, Nakanishi K, Matsushita K et al (2014) The role of basophils and proallergic cytokines, TSLP and IL-33, in cutaneously sensitized food allergy. Int Immunol 26:539–549. doi:10.1093/intimm/dxu058
109. Saluja R, Ketelaar ME, Hawro T, Church MK, Maurer M, Nawijn MC (2015) The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Mol Immunol 63:80–85. doi:10.1016/j.molimm.2014.06.018
110. Schneider E, Petit-Bertron A-F, Bricard R, Levasseur M, Ramadan A, Girard J-P et al (2009) IL-33 activates unprimed murine basophils directly in vitro and induces their in vivo expansion indirectly by promoting hematopoietic growth factor production. J Immunol 183:3591–3597. doi:10.4049/jimmunol.0900328
111. Suzukawa M, Iikura M, Koketsu R, Nagase H, Tamura C, Komiya A et al (2008) An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 181:5981–5989. doi:10.4049/jimmunol.181.9.5981
112. Junttila IS, Watson C, Kummola L, Chen X, Hu-Li J, Guo L et al (2013) Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3. J Allergy Clin Immunol 132:704–712. doi:10.1016/j.jaci.2013.03.033
113. Smithgall MD, Comeau MR, Yoon B-RP, Kaufman D, Armitage R, Smith DE (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells. Int Immunol 20:1019–1030. doi:10.1093/intimm/dxn060
114. Kim S, Prout M, Ramshaw H, Lopez AF, LeGros G, Min B (2010) Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3. J Immunol 184:1143–1147. doi:10.4049/jimmunol.0902447
115. Cianferoni A, Spergel J (2016) Eosinophilic esophagitis: a comprehensive review. Clin Rev Allergy Immunol 50:159–174. doi:10.1007/s12016-015-8501-z
116. Mulder DJ, Justinich CJ (2010) B cells, IgE and mechanisms of type I hypersensitivity in eosinophilic oesophagitis. Gut 59:6–7. doi:10.1136/gut.2009.189316
117. Stokes JR, Casale TB (2015) The use of anti-IgE therapy beyond allergic asthma. J Allergy Clin Immunol Pract 3:162–166. doi:10.1016/j.jaip.2014.10.010
118. Foroughi S, Foster B, Kim N, Bernardino LB, Scott LM, Hamilton RG et al (2007) Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol 120:594–601. doi:10.1016/j.jaci.2007.06.015
119. Gauvreau GM, O’Byrne PM, Boulet L-P, Wang Y, Cockcroft D, Bigler J et al (2014) Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med 370:2102–2110. doi:10.1056/NEJMoa1402895
120. Kambayashi T, Laufer TM (2014) Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat Rev Immunol 14:719–730. doi:10.1038/nri3754
121. M. Sarfati, K. Wakahara, L. Chapuy, G. Delespesse (2015) Mutual interaction of basophils and T cells in chronic inflammatory diseases, Front. Immunol. 6 doi:10.3389/fimmu.2015.00399
122. Otsuka A, Nakajima S, Kubo M, Egawa G, Honda T, Kitoh A et al (2013) Basophils are required for the induction of Th2 immunity to haptens and peptide antigens. Nat Commun 4:1738. doi:10.1038/ncomms2740
123. Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR et al (2009) MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol 10:697–705. doi:10.1038/ni.1740
124. Yoshimoto T, Yasuda K, Tanaka H, Nakahira M, Imai Y, Fujimori Y et al (2009) Basophils contribute to TH2-IgE responses in vivo via IL-4 production and presentation of peptide–MHC class II complexes to CD4+ T cells. Nat Immunol 10:706–712. doi:10.1038/ni.1737
125. Sokol CL, Barton GM, Farr AG, Medzhitov R (2008) A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 9:310–318. doi:10.1038/ni1558
126. Allenspach EJ, Lemos MP, Porrett PM, Turka LA, Laufer TM (2008) Migratory and lymphoid-resident dendritic cells cooperate to efficiently prime naive CD4 T cells. Immunity 29:795–806. doi:10.1016/j.immuni.2008.08.013
127. Hammad H, Plantinga M, Deswarte K, Pouliot P, Willart MAM, Kool M et al (2010) Inflammatory dendritic cells—not basophils—are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med 207:2097–2111. doi:10.1084/jem.20101563
128. Bonecchi R, Bianchi G, Bordignon PP, D’Ambrosio D, Lang R, Borsatti A et al (1998) Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187:129–134
129. Zaiss DMW, Gause WC, Osborne LC, Artis D (2015) Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair. Immunity 42:216–226. doi:10.1016/j.immuni.2015.01.020
130. Zaiss DMW, van Loosdregt J, Gorlani A, Bekker CPJ, Gröne A, Sibilia M et al (2013) Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor. Immunity 38:275–284. doi:10.1016/j.immuni.2012.09.023
131. Meulenbroeks C, van Weelden H, Schwartz C, Voehringer D, Redegeld FAM, Rutten VPMG et al (2015) Basophil-derived amphiregulin is essential for UVB irradiation–induced immune suppression. J Invest Dermatol 135:222–228. doi:10.1038/jid.2014.329
132. Qi Y, Operario DJ, Oberholzer CM, Kobie JJ, Looney RJ, Georas SN et al (2010) Human basophils express amphiregulin in response to T cell–derived IL-3. J Allergy Clin Immunol 126:1260–1266. doi:10.1016/j.jaci.2010.08.040
133. Stone KD, Prussin C, Metcalfe DD (2010) IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol 125:S73–S80. doi:10.1016/j.jaci.2009.11.017
134. Denzel A, Maus UA, Rodriguez Gomez M, Moll C, Niedermeier M, Winter C et al (2008) Basophils enhance immunological memory responses. Nat Immunol 9:733–742. doi:10.1038/ni.1621
135. Rodriguez Gomez M, Talke Y, Goebel N, Hermann F, Reich B, Mack M (2010) Basophils support the survival of plasma cells in mice. J Immunol 185:7180–7185. doi:10.4049/jimmunol.1002319
136. Charles N, Hardwick D, Daugas E, Illei GG, Rivera J (2010) Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med 16:701–707. doi:10.1038/nm.2159
137. Lack G, Fox D, Northstone K, Golding J (2003) Factors associated with the development of peanut allergy in childhood. N Engl J Med 348:977–985. doi:10.1056/NEJMoa013536
138. Han H, Thelen TD, Comeau MR, Ziegler SF (2014) Thymic stromal lymphopoietin–mediated epicutaneous inflammation promotes acute diarrhea and anaphylaxis. J Clin Invest 124:5442–5452. doi:10.1172/JCI77798
139. Ohnmacht C, Schwartz C, Panzer M, Schiedewitz I, Naumann R, Voehringer D (2010) Basophils orchestrate chronic allergic dermatitis and protective immunity against helminths. Immunity 33:364–374. doi:10.1016/j.immuni.2010.08.011
140. Jin G, Matsushita T, Hamaguchi Y, Le Huu D, Ishii T, Hasegawa M et al (2012) Basophils and mast cells play critical roles for leukocyte recruitment in IgE-mediated cutaneous reverse passive Arthus reaction. J Dermatol Sci 67:181–189. doi:10.1016/j.jdermsci.2012.06.005
141. Nakashima C, Otsuka A, Kitoh A, Honda T, Egawa G, Nakajima S et al (2014) Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis. J Allergy Clin Immunol 134:100–107. doi:10.1016/j.jaci.2014.02.026
142. Cheng LE, Sullivan BM, Retana LE, Allen CDC, Liang H-E, Locksley RM (2015) IgE-activated basophils regulate eosinophil tissue entry by modulating endothelial function. J Exp Med 212:513–524. doi:10.1084/jem.20141671
143. Borchers MT, Ansay T, DeSalle R, Daugherty BL, Shen H, Metzger M et al (2002) In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration. J Leukoc Biol 71:1033–1041
144. Van Dyken SJ, Locksley RM (2013) Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 31:317–343. doi:10.1146/annurev-immunol-032712-095906
145. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD et al (2014) Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood 123:e110–e122. doi:10.1182/blood-2013-08-520619
146. Han H, Headley MB, Xu W, Comeau MR, Zhou B, Ziegler SF (2013) Thymic stromal lymphopoietin amplifies the differentiation of alternatively activated macrophages. J Immunol 190:904–912. doi:10.4049/jimmunol.1201808
147. Huang SC-C, Everts B, Ivanova Y, O’Sullivan D, Nascimento M, Smith AM et al (2014) Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol 15:846–855. doi:10.1038/ni.2956
148. Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35. doi:10.1038/nri978
149. Obata-Ninomiya K, Ishiwata K, Tsutsui H, Nei Y, Yoshikawa S, Kawano Y et al (2013) The skin is an important bulwark of acquired immunity against intestinal helminths. J Exp Med 210:2583–2595. doi:10.1084/jem.20130761
150. Griffith JW, Sokol CL, Luster AD (2014) Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol 32:659–702. doi:10.1146/annurev-immunol-032713-120145
151. Xue J, Schmidt SV, Sander J, Draffehn A, Krebs W, Quester I et al (2014) Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40:274–288. doi:10.1016/j.immuni.2014.01.006
152. Kim BS (2015) Innate lymphoid cells in the skin. J Invest Dermatol 135:673–678. doi:10.1038/jid.2014.401
153. Artis D, Spits H (2015) The biology of innate lymphoid cells. Nature 517:293–301. doi:10.1038/nature14189
154. von Moltke J, Locksley RM (2014) I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis. Curr Opin Immunol 31:58–65. doi:10.1016/j.coi.2014.09.009
155. Motomura Y, Morita H, Moro K, Nakae S, Artis D, Endo TA et al (2014) Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity 40:758–771. doi:10.1016/j.immuni.2014.04.013
156. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, Doering TA et al (2011) Innate lymphoid cells promote lung tissue homeostasis following acute influenza virus infection. Nat Immunol 12:1045–1054. doi:10.1031/ni.2131
157. Beck LA, Thaçi D, Hamilton JD, Graham NM, Bieber T, Rocklin R et al (2014) Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 371:130–139. doi:10.1056/NEJMoa1314768
158. Thaçi D, Simpson EL, Beck LA, Bieber T, Blauvelt A, Papp K et al (2015) Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial. Lancet Lond, Engl. doi:10.1016/S0140-6736(15)00388-8
159. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F et al (2013) Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368:2455–2466. doi:10.1056/NEJMoa1304048